Q2N9J2 AF NFT

Dual-specificity RNA methyltransferase RlmN

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeigtv52k3xqfzcrun65neoq3kptd3nxthoja56umafqj6h3rdawrp4/metadata.json
IPFS of structure file: 
bafybeialav65vzsejckttte66ph3ei4rwjkngl3b72m3oohgl7malwulma/AF-Q2N9J2-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x272511D5F14E62CC0ef5f0eB6Ac2c4A390EfC88b
First NFT owner address (bech32): 
genesis1yuj3r403fe3vcrh47r4k4sky5wgwljytevg9vk
Current NFT ID #378271 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
378271
Accession (UniProt):
Q2N9J2
Name::
Dual-specificity RNA methyltransferase RlmN
Experimental Method:
Predicted structure
Sequence source:
ERYTHROBACTER LITORALIS (STRAIN HTCC2594)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q2N9J2 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q2N9J2|RLMN_ERYLH Dual-specificity RNA methyltransferase RlmN OS=Erythrobacter litoralis (strain HTCC2594) OX=314225 GN=rlmN PE=3 SV=1 MADTSLMPIPGQVDPVPAPRDITPRADGRVDLMGLPKARIQELFAEAGLDAKQAKLRSKQVYHWLYHRGVTDFEAMTDIAKTMRPWLAERFIVGRPNVVEAQHSTDGTRKWLLQTDDGHDFEMVFIPDADRGTLCVSSQVGCTLNCRFCHTGTMRLVRNLTPGEIVGQVMLARDALGEWPKGRMDGLDDVEDTGHYSADGRLLTNIVMMGMGEPLYNFDNVRDALKLVMDGEGLALSKRRITLSTSGVVPMMERCGEEIGVNLAVSLHAVTKDIRDEIVPINKKYGIEELLQACADYPGASNARRITFEYVMLKDKNDTDEHARELVRLLKQYNLPAKVNLIPFNPWPGAAYECSTPERIRAFSNIVFEGGISAPVRTPRGRDIDAACGQLKTAAQKKSRAERDREAAAEAEAAASQA